A Double-Blind, Randomized,Placebo Controlled Study of Alfuzosin 10mg od in the Return to Successful Voiding in Patients With a First Episode of Acute Urinary Retention Due to Benign Prostatic Hyperplasia.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Mar 2009 Actual patient number (156) added as reported by ClinicalTrials.gov.
- 09 Mar 2009 Trial phase changed from III to II as reported by ClinicalTrials.gov.
- 17 Mar 2008 Status changed from in progress to completed on clinicaltrials.gov.